Columbus Venture Partners is a Spanish independent venture capital that brings a unique approach for investing in outstanding early-stage and high growth opportunities in the life science industry of Spain.
Our team includes solid and internationally experienced investment professionals with a deep scientific, medical and business development background combined with a proven experience in building and investing in companies to accelerate their commercialization.
The combination of industry possibilities and investment experience will provide Limited Partner investors in the Fund a level of professionality and deep expertise that is essential for success in this field.
WHY COLUMBUS VENTURES PARTNERS
Christopher Columbus, one of the great entrepreneurs who changed the history of mankind, always thought big. A true visionary, Columbus was resilient, able to adapt to challenges, and willing to take risks. Five hundred years ago, Columbus spent seven years pitching his business plan to Genoese bankers (the world’s first angel networks) before convincing Castile’s King Ferdinand and Queen Isabella to fund his crackpot scheme. This resulted in the world´s first term-sheet “Capitulations of Santa Fe”. This venture capital project resulted in a discovery that changed the fate of the world.
- Area of Activity
- Venture Capital - General
- Venture Capital Investors in Health and Medical sector
- Venture Capital Investors in Biotechnology
- Private Equity Investors in Health and Medical sector
- Private Equity sector
- Private Equity Investors in Biotechnology
- Company type
- Venture Capital
- Private Equity
C/ José Abascal, 58-7 derecha
Madrid, Madrid 28003, ES
P: +34 910 571 655
Roger de Lauria, 6, 6ºA,
Valencia, Valencia 46002, ES
P: 963 94 65 99
Chief Financial Officer
Senior Finance Analyst
Executive Assistant and Corporate Communications
Executive Assistant and Head of Administration
Head of Legal
Finance & Operations Support Team
Finance & Operations Support Team
Jose Vicente Pons
COLUMBUS INNVIERTE LIFE SCIENCE
Columbus Venture Partners’ investment strategy is focused on early-stage and high growth opportunities of biotechnology, medical technology, pharmaceuticals and healthcare industries.
We have analyzed in detail the Spanish biotechnology sector, and have contrasted the opportunities for private investors, other venture capital funds, and pharmaceutical and biotechnology companies. Our conclusion is there is a huge opportunity to develop ideas and to transfer out advance technology of Universities and Research Centers into market driven companies.
THE EFFICIENT FRONTIER: A DIVERSIFIED PORTFOLIO WITH OPTIMIZED RISK – RETURN. WELL KNOWN MODERN PORTOFOLIOS THEORY AT ITS BEST
● Search of deal flow in Research Centers and early stage assets from existing companies.
● Collaboration agreements with TLOs.
● Assestment market needs.
● IP Position.
● Commercial Viability.
● Resources needed, timelines and milestones.
● Business Plan.
● Scientific/Tech validation.
● Project Development.
HOPE ACCELERATES HERE
At Columbus Venture Partners we believe that innovation has a real impact on society and, in particular, on those with the greatest needs. However, pharmaceutical developments focus on indications or diseases that, due to the number of patients, have a positive economic return potential on the executed investment. Therefore, ultra-rare disease treatments are often hampered not for technical reasons but for cost-effectiveness. For that reason, our goal from Columbus is to bring these cutting-edge innovations forward so that research and development of treatments for these ultra-rare diseases advance at the same rate as other larger indications. Children with these diseases and their families need an urgently access to these transformative medicines. Most of them suffer from a severely altered lifestyle, and in many cases life expectancy is less than ten years. At Columbus Venture Partners we are deeply motivated by the urgent needs to ensure that no child is left behind. Thus, we work with the Columbus Foundation (Spain) and the Columbus Children Foundation (USA) in collaboration with Askbio and Viralgen to provide a solution to these diseases.
You can follow our activity at the Columbus Foundation (Spain) and the Columbus Children Foundation (USA).
IMPROVED INVESTMENT STRATEGY LEVERAGES RETURN
High value with alternative and attractive risk/reward profiles, commercially and scientifically differentiated.
Lean structure, cost efficient, accessible shared resources, access to low-cost incubator.
Hands-on investments. Founder ROI in investments: leverages return. Board role in 100% of the investments in the portfolio.
Projects co-invested or partnered with global VC firms and Top pharmaceutical companies. Preferred access to novel technologies.